Patients Coming Off Slimming Jabs Gain Back Pounds Four Times Faster Compared to Those on Conventional Diets

New research reveals that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who stop traditional diet and exercise plans.

Findings released in a major medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.

"Individuals purchasing these drugs need to be aware of the risk of fast rebound weight gain when the medication is stopped," cautioned researcher Dr. Susan Jebb.

This pace of recovery implies a return to starting weight within about 18 months.

Comparing Approaches

The research, which reviewed dozens of studies involving thousands of participants, contrasted the outcomes of the injectable medications with conventional dieting.

The team note that people who shed pounds through dieting usually see a more gradual creep back—perhaps 100 grams monthly—post-intervention.

The Reason for the Rapid Rebound

Nutrition scientists suggest the mechanism of the drugs is key to understanding the heightened regain.

The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication means hunger is unsuppressed, making binge eating a significant risk."

A Chronic Condition?

Health authorities suggest the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.

A number of clinicians say that, considering the likelihood of weight regain, the therapy should be considered ongoing.

This perspective is reinforced by pharmaceutical companies, who note that the results "underscore the long-term nature of excess weight," similar to managing conditions like hypertension.

Patient Testimonies

People who have discontinued the medication explain a intense return of cravings.

"It was like a trigger that goes on and you become ravenous," described an individual.

The struggle is exacerbated if patients have not developed permanent lifestyle or habit changes during treatment.

Significant Use

Recent estimates show that millions of people in the UK have used these injections in the past year, with desire being substantial.

• Use is more common among females than men.
• The middle-aged age group shows the highest level of interest.
• Many access the medications through private prescriptions rather than the NHS.

In conclusion, researchers caution that while these medications are powerful tools for weight loss, they are not a standalone cure and lasting health benefits hinges on integrated behavioural changes.